KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 65 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,867,112 | -53.4% | 276,200 | 0.0% | 0.04% | -53.2% |
| Q3 2022 | $4,008,000 | +118.2% | 276,200 | +99.0% | 0.08% | +243.5% |
| Q4 2021 | $1,837,000 | -84.2% | 138,821 | -79.1% | 0.02% | -85.0% |
| Q3 2021 | $11,616,000 | -27.2% | 665,681 | 0.0% | 0.15% | -28.5% |
| Q2 2021 | $15,950,000 | -54.8% | 665,681 | -51.5% | 0.21% | -59.1% |
| Q1 2021 | $35,272,000 | +10.6% | 1,373,000 | -18.3% | 0.52% | +7.0% |
| Q4 2020 | $31,903,000 | +50.8% | 1,680,000 | 0.0% | 0.49% | +18.1% |
| Q3 2020 | $21,151,000 | +4.0% | 1,680,000 | 0.0% | 0.41% | -6.3% |
| Q2 2020 | $20,328,000 | +58.2% | 1,680,000 | 0.0% | 0.44% | +6.2% |
| Q1 2020 | $12,852,000 | -57.0% | 1,680,000 | 0.0% | 0.42% | -50.7% |
| Q4 2019 | $29,921,000 | +53.5% | 1,680,000 | 0.0% | 0.84% | +30.9% |
| Q3 2019 | $19,488,000 | -41.3% | 1,680,000 | +12.0% | 0.64% | -36.2% |
| Q2 2019 | $33,225,000 | +29.0% | 1,500,000 | +66.7% | 1.01% | +14.0% |
| Q1 2019 | $25,758,000 | +44.9% | 900,000 | 0.0% | 0.89% | +12.6% |
| Q4 2018 | $17,775,000 | -10.7% | 900,000 | 0.0% | 0.79% | +7.7% |
| Q3 2018 | $19,899,000 | +172.3% | 900,000 | 0.0% | 0.73% | +141.3% |
| Q2 2018 | $7,308,000 | -14.3% | 900,000 | 0.0% | 0.30% | -24.1% |
| Q1 2018 | $8,532,000 | +23.4% | 900,000 | +26.9% | 0.40% | +10.8% |
| Q4 2017 | $6,913,000 | +162.2% | 709,000 | +79.0% | 0.36% | +141.6% |
| Q3 2017 | $2,637,000 | +92.9% | 396,000 | +108.5% | 0.15% | +75.3% |
| Q2 2017 | $1,367,000 | +78.5% | 189,900 | +93.6% | 0.08% | +66.7% |
| Q1 2017 | $766,000 | – | 98,100 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
| TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
| TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
| Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
| Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
| GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
| DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
| Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |